XPOVIO® Now Funded in Nova Scotia

Oct 6, 2023

FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Nova Scotia as of October 1st. Please see the following link for full funding criteria: Nova Scotia Pharmacare News Bulletins Pharmacy Edition (

We are excited about this important milestone for patients in Nova Scotia.

Read on LinkedIn